Crews L - Search Results

1

Climbing the scaffolds of Parkinson's disease pathogenesis.

Spencer B, Crews L, Masliah E. Spencer B, et al. Among authors: crews l. Neuron. 2007 Feb 15;53(4):469-70. doi: 10.1016/j.neuron.2007.02.002. Neuron. 2007. PMID: 17296545 Free article.

2

Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.

Hashimoto M, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. Among authors: crews l. Neuromolecular Med. 2003;4(1-2):21-36. doi: 10.1385/NMM:4:1-2:21. Neuromolecular Med. 2003. PMID: 14528050 Review.

3

Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease.

Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. Among authors: crews l. J Biol Chem. 2004 May 28;279(22):23622-9. doi: 10.1074/jbc.M313784200. Epub 2004 Mar 16. J Biol Chem. 2004. PMID: 15026413 Free article.

4

Insights into the pathogenesis of hydrocephalus from transgenic and experimental animal models.

Crews L, Wyss-Coray T, Masliah E. Crews L, et al. Brain Pathol. 2004 Jul;14(3):312-6. doi: 10.1111/j.1750-3639.2004.tb00070.x. Brain Pathol. 2004. PMID: 15446587 Free PMC article. Review.

5

An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.

Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, Marr R, Masliah E. Hashimoto M, et al. Among authors: crews l. Gene Ther. 2004 Dec;11(23):1713-23. doi: 10.1038/sj.gt.3302349. Gene Ther. 2004. PMID: 15483670

6

Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis.

Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS. Masliah E, et al. Among authors: crews l. J Neuroimmunol. 2004 Dec;157(1-2):163-75. doi: 10.1016/j.jneuroim.2004.08.026. J Neuroimmunol. 2004. PMID: 15579294

7

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.

Masliah E, Hansen L, Adame A, Crews L, Bard F, Lee C, Seubert P, Games D, Kirby L, Schenk D. Masliah E, et al. Among authors: crews l. Neurology. 2005 Jan 11;64(1):129-31. doi: 10.1212/01.WNL.0000148590.39911.DF. Neurology. 2005. PMID: 15642916

8

The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.

Hashimoto M, Kawahara K, Bar-On P, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. Among authors: crews l. J Mol Neurosci. 2004;24(3):343-52. doi: 10.1385/JMN:24:3:343. J Mol Neurosci. 2004. PMID: 15655259 Review.

9

Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin.

Rockenstein E, Adame A, Mante M, Larrea G, Crews L, Windisch M, Moessler H, Masliah E. Rockenstein E, et al. Among authors: crews l. J Neural Transm (Vienna). 2005 Feb;112(2):269-82. doi: 10.1007/s00702-004-0181-4. Epub 2004 Jul 7. J Neural Transm (Vienna). 2005. PMID: 15657642

10

Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.

Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, Pfragner R, Schreiner E, Windisch M, Masliah E. Rockenstein E, et al. Among authors: crews l. J Neurosci Res. 2005 Apr 15;80(2):247-59. doi: 10.1002/jnr.20446. J Neurosci Res. 2005. PMID: 15765523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters